LVW Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$616K Buy
7,217
+3
+0% +$272 0.05% 219
2026
Q2
$661K Sell
7,214
-638
-8% -$55.8K 0.06% 183
2026
Q1
$669K Sell
7,852
-1,924
-20% -$171K 0.06% 163
2025
Q4
$772K Buy
9,776
+2,230
+30% +$175K 0.08% 120
2025
Q3
$603K Sell
7,546
-2,746
-27% -$234K 0.06% 163
2025
Q2
$936K Buy
10,292
+5,224
+103% +$477K 0.1% 118
2025
Q1
$475K Sell
5,068
-320
-6% -$28.7K 0.06% 177
2024
Q4
$490K Buy
5,388
+597
+12% +$57K 0.06% 193
2024
Q3
$497K Buy
4,791
+1,891
+65% +$193K 0.06% 186
2024
Q2
$281K Buy
+2,900
New +$268K 0.04% 239

Other funds holding CL

LVW Advisors's CL Position: Q3 2026 in Review

LVW Advisors increased its Colgate-Palmolive (CL) stake by 0.04% in Q3 2026, buying an estimated $272 and bringing the position to 7,217 shares worth $616K. The position accounts for 0.05% of the portfolio, ranked #219.

LVW Advisors first reported a position in CL in Q2 2024 and has held it in 10 quarters since. The position peaked at $936K in Q2 2025. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • LVW Advisors held 7,217 shares of Colgate-Palmolive worth $616K as of Q3 2026.
  • LVW Advisors bought 3 Colgate-Palmolive shares in Q3 2026, an estimated $272.
  • Colgate-Palmolive made up 0.05% of LVW Advisors's portfolio in Q3 2026, its #219 holding.
  • LVW Advisors first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 10 quarters since.
  • LVW Advisors's Colgate-Palmolive position peaked at $936K in Q2 2025.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on LVW Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.